Quest Diagnostics Incorporated
Robert B Carter (Director) reports DGX insider transactions
AI-generated summary
Director Robert B Carter acquired 10 shares of Common Stock at an average price of $235.93 per share, with a total value of $2,359.30, on October 21, 2026. Following the transaction, the insider directly holds 3,874 shares. The transaction was a Code L acquisition.
Key facts
- Insider
- Robert B Carter · Director
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Oct 21, 2026 | LFootnotes F1 | +10 | $235.93 | $2,359.30 | 3,874 | Direct |
Footnotes
- F1 Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.
More DGX filings
- 4
Filed Oct 28, 2026
- 144
Filed Oct 26, 2026
- 4
Filed Oct 23, 2026
- 4
Filed Oct 23, 2026
- 4
Filed Oct 23, 2026
- 4
Filed Oct 23, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.